Most bought healthcare stocks in Q2 2022
See which Healthcare stocks institutional investors increased the most in Q2 2022, measured as net growth in reported share positions from Q1 2022 into Q2 2022. Notable additions at the top of this list include ELANCO ANIMAL HEALTH INC (ELAN), TELADOC HEALTH INC (TDOC), AGILON HEALTH INC (AGL), BAUSCH + LOMB CORP (BLCO). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ELAN | ELANCO ANIMAL HEALTH INC | 20,013,519 | $175.72K | 0 | 1 | 2 | 1 | 3 |
| TDOC | TELADOC HEALTH INC | 4,845,331 | -$596.67K | 0 | 2 | 0 | 0 | 2 |
| AGL | AGILON HEALTH INC | 4,197,772 | $81.11K | 1 | 1 | 0 | 0 | 2 |
| BLCO | BAUSCH + LOMB CORP | 3,500,000 | $53.34K | 1 | 0 | 0 | 0 | 1 |
| OPK | OPKO HEALTH INC | 3,386,058 | $8.01K | 0 | 1 | 0 | 1 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 3,092,778 | $243.01K | 1 | 5 | 3 | 0 | 9 |
| GDRX | GOODRX HOLDINGS INC-CLASS A | 2,859,300 | $11.75K | 0 | 1 | 0 | 0 | 1 |
| EMBC | EMBECTA CORP | 2,723,301 | $68.95K | 3 | 0 | 0 | 0 | 3 |
| ZOM | ZOMEDICA CORP | 2,507,500 | $550 | 1 | 0 | 0 | 0 | 2 |
| INCY | INCYTE CORP | 2,408,710 | $100.01K | 0 | 2 | 2 | 0 | 4 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 2,292,300 | $23.15K | 0 | 1 | 0 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | 2,050,369 | $77.19K | 1 | 3 | 1 | 1 | 5 |
| BLUE | BLUEBIRD BIO INC | 1,870,000 | $7.07K | 0 | 1 | 0 | 0 | 1 |
| ACHC | ACADIA HEALTHCARE CO INC | 1,843,930 | $129.38K | 1 | 2 | 0 | 1 | 3 |
| PEPG | PEPGEN INC | 1,793,923 | $17.81K | 1 | 0 | 0 | 0 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1,761,480 | -$135.86K | 0 | 1 | 1 | 2 | 3 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 1,734,910 | -$78.04K | 1 | 1 | 1 | 0 | 4 |
| MCK | MCKESSON CORP | 1,606,202 | $638.25K | 2 | 2 | 2 | 0 | 6 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,582,809 | $258.13K | 1 | 3 | 2 | 0 | 6 |
| OSUR | ORASURE TECHNOLOGIES INC | 1,496,116 | $341 | 0 | 1 | 0 | 0 | 1 |
| VTRS | VIATRIS INC | 1,427,033 | -$141.73K | 0 | 1 | 1 | 0 | 3 |
| ABCL | ABCELLERA BIOLOGICS INC | 1,418,700 | $17.46K | 0 | 1 | 0 | 0 | 1 |
| CAH | CARDINAL HEALTH INC | 1,415,579 | $56.48K | 2 | 1 | 2 | 0 | 6 |
| ACCD | ACCOLADE INC | 1,413,401 | -$49.53K | 0 | 2 | 0 | 0 | 2 |
| CDNA | CAREDX INC | 1,211,792 | -$19.79K | 0 | 3 | 0 | 0 | 3 |
| AQST | AQUESTIVE THERAPEUTICS INC | 1,192,100 | $695 | 0 | 1 | 0 | 0 | 1 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 1,094,252 | -$214.46K | 0 | 2 | 0 | 0 | 3 |
| AMGN | AMGEN INC | 1,045,900 | $255.98K | 0 | 2 | 5 | 0 | 7 |
| SY | SO-YOUNG INTERNATIONAL-ADR | 1,030,300 | $464 | 0 | 1 | 0 | 0 | 1 |
| STXS | STEREOTAXIS INC | 1,009,631 | -$2.57K | 0 | 2 | 0 | 0 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 1,003,466 | -$46.60K | 0 | 1 | 0 | 0 | 1 |
| CVS | CVS HEALTH CORP | 985,293 | -$42.10K | 0 | 3 | 6 | 0 | 9 |
| TGTX | TG THERAPEUTICS INC | 983,500 | $3.14K | 0 | 1 | 0 | 0 | 1 |
| ME | 23ANDME HOLDING CO -CLASS A | 970,200 | -$411 | 0 | 1 | 1 | 1 | 2 |
| MRVI | MARAVAI LIFESCIENCES HLDGS-A | 961,800 | $21.06K | 0 | 1 | 0 | 0 | 1 |
| EXEL | EXELIXIS INC | 921,659 | -$12.04K | 0 | 1 | 0 | 0 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 917,590 | $59.05K | 0 | 2 | 3 | 0 | 5 |
| HOLX | HOLOGIC INC | 877,814 | -$229.67K | 0 | 1 | 3 | 0 | 5 |
| DXCM | DEXCOM INC | 871,372 | $54.80K | 0 | 1 | 0 | 0 | 1 |
| BEAM | BEAM THERAPEUTICS INC | 871,215 | -$149.76K | 1 | 1 | 0 | 0 | 2 |
| MGNX | MACROGENICS INC | 845,211 | -$939 | 0 | 1 | 0 | 0 | 1 |
| PSNL | PERSONALIS INC | 835,436 | -$19.40K | 0 | 2 | 0 | 0 | 2 |
| SPRO | SPERO THERAPEUTICS INC | 829,917 | -$253 | 0 | 1 | 0 | 0 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 816,630 | $23.85K | 1 | 1 | 0 | 0 | 2 |
| TMO | THERMO FISHER SCIENTIFIC INC | 798,928 | $238.37K | 0 | 5 | 3 | 1 | 11 |
| MRK | MERCK & CO. INC. | 790,939 | $6.90M | 0 | 6 | 6 | 0 | 14 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 781,053 | $48.57K | 1 | 1 | 2 | 0 | 4 |
| ALHC | ALIGNMENT HEALTHCARE INC | 771,523 | $9.89K | 0 | 2 | 0 | 0 | 2 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 751,467 | -$63.18K | 0 | 1 | 2 | 1 | 4 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 740,118 | $9.38K | 0 | 1 | 2 | 0 | 3 |
Frequently asked questions about Most bought healthcare stocks in Q2 2022
What are the most bought Healthcare stocks in Q2 2022?
The most bought healthcare stocks in Q2 2022 are those with the largest increase in reported share counts across tracked institutional investors compared to Q1 2022, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2022?
Among the managers we track, net additions were largest in companies such as ELANCO ANIMAL HEALTH INC (ELAN), TELADOC HEALTH INC (TDOC), AGILON HEALTH INC (AGL), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q1 2022).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.